APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paediatric Influenza Prevention

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Paediatric Influenza Prevention Industry Growth and Trends Forecast to 2032

28 December 2025105 pages

Choose your research edition.

Industry ResearchPaediatric Influenza Prevention Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Paediatric Influenza Prevention Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Paediatric Influenza Prevention Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paediatric Influenza Prevention Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Paediatric Influenza Prevention Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Paediatric Influenza Prevention market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Paediatric Influenza Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Paediatric Influenza Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Paediatric Influenza Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Paediatric Influenza Prevention include Sanofi, Jiangsu GDK, GSK, Viatris, Sinovac, KM Biologics, Hulan Bio, CSL and CCBIO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Paediatric Influenza Prevention market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paediatric Influenza Prevention market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paediatric Influenza Prevention market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paediatric Influenza Prevention.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paediatric Influenza Prevention market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paediatric Influenza Prevention Market by Company

Sanofi

Jiangsu GDK

GSK

Viatris

Sinovac

KM Biologics

Hulan Bio

CSL

CCBIO

BCHT

AstraZeneca

Paediatric Influenza Prevention Segment by Type

Nasal Spray

Injection

Paediatric Influenza Prevention Segment by Application

Public

Private

Paediatric Influenza Prevention Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paediatric Influenza Prevention market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paediatric Influenza Prevention and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paediatric Influenza Prevention.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paediatric Influenza Prevention manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paediatric Influenza Prevention in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Spray Table 2. Major Company of Injection Table 3. Global Paediatric Influenza Prevention Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units) Table 5. Global Paediatric Influenza Prevention Sales Market Share in Volume by Type (2021-2026) Table 6. Global Paediatric Influenza Prevention Sales by Type (2021-2026) & (US$ Million) Table 7. Global Paediatric Influenza Prevention Sales Market Share in Value by Type (2021-2026) Table 8. Global Paediatric Influenza Prevention Price by Type (2021-2026) & (US$/Unit) Table 9. Global Paediatric Influenza Prevention Sales by Type (2027-2032) & (K Units) Table 10. Global Paediatric Influenza Prevention Sales Market Share in Volume by Type (2027-2032) Table 11. Global Paediatric Influenza Prevention Sales by Type (2027-2032) & (US$ Million) Table 12. Global Paediatric Influenza Prevention Sales Market Share in Value by Type (2027-2032) Table 13. Global Paediatric Influenza Prevention Price by Type (2027-2032) & (US$/Unit) Table 14. North America Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units) Table 15. North America Paediatric Influenza Prevention Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units) Table 17. Europe Paediatric Influenza Prevention Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Paediatric Influenza Prevention Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units) Table 21. Latin America Paediatric Influenza Prevention Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Paediatric Influenza Prevention Sales by Type (2021-2026) & (US$ Million) Table 24. Paediatric Influenza Prevention Industry Trends Table 25. Paediatric Influenza Prevention Industry Drivers Table 26. Paediatric Influenza Prevention Industry Opportunities and Challenges Table 27. Paediatric Influenza Prevention Industry Restraints Table 28. Global Paediatric Influenza Prevention Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Paediatric Influenza Prevention Revenue Market Share by Company (2021-2026) Table 30. Global Paediatric Influenza Prevention Sales by Company (2021-2026) & (K Units) Table 31. Global Paediatric Influenza Prevention Sales Share by Company (2021-2026) Table 32. Global Paediatric Influenza Prevention Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Paediatric Influenza Prevention Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Paediatric Influenza Prevention Major Company Production Sites and Headquarters Table 35. Global Paediatric Influenza Prevention Company, Product Type & Application Table 36. Global Paediatric Influenza Prevention Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Paediatric Influenza Prevention by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Paediatric Influenza Prevention Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Paediatric Influenza Prevention Sales by Region (2021-2026) & (K Units) Table 41. Global Paediatric Influenza Prevention Sales Market Share in Volume by Region (2021-2026) Table 42. Global Paediatric Influenza Prevention Sales by Region (2021-2026) & (US$ Million) Table 43. Global Paediatric Influenza Prevention Sales Market Share in Value by Region (2021-2026) Table 44. Global Paediatric Influenza Prevention Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Paediatric Influenza Prevention Sales by Region (2027-2032) & (K Units) Table 46. Global Paediatric Influenza Prevention Sales Market Share in Volume by Region (2027-2032) Table 47. Global Paediatric Influenza Prevention Sales by Region (2027-2032) & (US$ Million) Table 48. Global Paediatric Influenza Prevention Sales Market Share in Value by Region (2027-2032) Table 49. Global Paediatric Influenza Prevention Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Paediatric Influenza Prevention Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units) Table 52. Global Paediatric Influenza Prevention Sales Market Share in Volume by Application (2021-2026) Table 53. Global Paediatric Influenza Prevention Sales by Application (2021-2026) & (US$ Million) Table 54. Global Paediatric Influenza Prevention Sales Market Share in Value by Application (2021-2026) Table 55. Global Paediatric Influenza Prevention Price by Application (2021-2026) & (US$/Unit) Table 56. Global Paediatric Influenza Prevention Sales by Application (2027-2032) & (K Units) Table 57. Global Paediatric Influenza Prevention Sales Market Share in Volume by Application (2027-2032) Table 58. Global Paediatric Influenza Prevention Sales by Application (2027-2032) & (US$ Million) Table 59. Global Paediatric Influenza Prevention Sales Market Share in Value by Application (2027-2032) Table 60. Global Paediatric Influenza Prevention Price by Application (2027-2032) & (US$/Unit) Table 61. North America Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units) Table 62. North America Paediatric Influenza Prevention Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units) Table 64. Europe Paediatric Influenza Prevention Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Paediatric Influenza Prevention Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units) Table 68. Latin America Paediatric Influenza Prevention Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Paediatric Influenza Prevention Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Paediatric Influenza Prevention Product Portfolio Table 75. Sanofi Recent Development Table 76. Jiangsu GDK Company Information Table 77. Jiangsu GDK Business Overview Table 78. Jiangsu GDK Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Jiangsu GDK Paediatric Influenza Prevention Product Portfolio Table 80. Jiangsu GDK Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Paediatric Influenza Prevention Product Portfolio Table 85. GSK Recent Development Table 86. Viatris Company Information Table 87. Viatris Business Overview Table 88. Viatris Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Viatris Paediatric Influenza Prevention Product Portfolio Table 90. Viatris Recent Development Table 91. Sinovac Company Information Table 92. Sinovac Business Overview Table 93. Sinovac Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sinovac Paediatric Influenza Prevention Product Portfolio Table 95. Sinovac Recent Development Table 96. KM Biologics Company Information Table 97. KM Biologics Business Overview Table 98. KM Biologics Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. KM Biologics Paediatric Influenza Prevention Product Portfolio Table 100. KM Biologics Recent Development Table 101. Hulan Bio Company Information Table 102. Hulan Bio Business Overview Table 103. Hulan Bio Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hulan Bio Paediatric Influenza Prevention Product Portfolio Table 105. Hulan Bio Recent Development Table 106. CSL Company Information Table 107. CSL Business Overview Table 108. CSL Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CSL Paediatric Influenza Prevention Product Portfolio Table 110. CSL Recent Development Table 111. CCBIO Company Information Table 112. CCBIO Business Overview Table 113. CCBIO Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CCBIO Paediatric Influenza Prevention Product Portfolio Table 115. CCBIO Recent Development Table 116. BCHT Company Information Table 117. BCHT Business Overview Table 118. BCHT Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. BCHT Paediatric Influenza Prevention Product Portfolio Table 120. BCHT Recent Development Table 121. AstraZeneca Company Information Table 122. AstraZeneca Business Overview Table 123. AstraZeneca Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. AstraZeneca Paediatric Influenza Prevention Product Portfolio Table 125. AstraZeneca Recent Development Table 126. North America Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units) Table 128. North America Paediatric Influenza Prevention Sales Market Share by Country (2021-2026) Table 129. North America Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Paediatric Influenza Prevention Sales Market Share Forecast by Country (2027-2032) Table 131. North America Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Paediatric Influenza Prevention Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Paediatric Influenza Prevention Market Share by Country (2021-2026) Table 134. North America Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Paediatric Influenza Prevention Market Share Forecast by Country (2027-2032) Table 136. Europe Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units) Table 138. Europe Paediatric Influenza Prevention Sales Market Share by Country (2021-2026) Table 139. Europe Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Paediatric Influenza Prevention Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Paediatric Influenza Prevention Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Paediatric Influenza Prevention Market Share by Country (2021-2026) Table 144. Europe Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Paediatric Influenza Prevention Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Paediatric Influenza Prevention Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Paediatric Influenza Prevention Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Paediatric Influenza Prevention Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Paediatric Influenza Prevention Market Share by Country (2021-2026) Table 154. Asia-Pacific Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Paediatric Influenza Prevention Market Share Forecast by Country (2027-2032) Table 156. Latin America Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units) Table 158. Latin America Paediatric Influenza Prevention Sales Market Share by Country (2021-2026) Table 159. Latin America Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Paediatric Influenza Prevention Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Paediatric Influenza Prevention Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Paediatric Influenza Prevention Market Share by Country (2021-2026) Table 164. Latin America Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Paediatric Influenza Prevention Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Paediatric Influenza Prevention Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Paediatric Influenza Prevention Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Paediatric Influenza Prevention Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Paediatric Influenza Prevention Market Share by Country (2021-2026) Table 174. Middle East and Africa Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Paediatric Influenza Prevention Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Paediatric Influenza Prevention Distributors List Table 179. Paediatric Influenza Prevention Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Paediatric Influenza Prevention Image Figure 2. Global Paediatric Influenza Prevention Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paediatric Influenza Prevention Market Size (2021-2032) & (US$ Million) Figure 4. Global Paediatric Influenza Prevention Sales (2021-2032) & (K Units) Figure 5. Nasal Spray Image Figure 6. Global Nasal Spray Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Paediatric Influenza Prevention Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Paediatric Influenza Prevention Market Share by Type 2025 VS 2032 Figure 11. North America Paediatric Influenza Prevention Sales Market Share in Volume by Type in 2025 Figure 12. North America Paediatric Influenza Prevention Sales Market Share in Value by Type in 2025 Figure 13. Europe Paediatric Influenza Prevention Sales Market Share in Volume by Type in 2025 Figure 14. Europe Paediatric Influenza Prevention Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Paediatric Influenza Prevention Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Paediatric Influenza Prevention Sales Market Share in Value by Type in 2025 Figure 17. Latin America Paediatric Influenza Prevention Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Paediatric Influenza Prevention Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Paediatric Influenza Prevention Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Paediatric Influenza Prevention Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Paediatric Influenza Prevention Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Image Figure 24. Global Public Sales YoY Growth (2021-2032) & (K Units) Figure 25. Private Image Figure 26. Global Private Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Paediatric Influenza Prevention Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Paediatric Influenza Prevention Market Share by Application 2025 VS 2032 Figure 29. North America Paediatric Influenza Prevention Sales Market Share in Volume by Application in 2025 Figure 30. North America Paediatric Influenza Prevention Sales Market Share in Value by Application in 2025 Figure 31. Europe Paediatric Influenza Prevention Sales Market Share in Volume by Application in 2025 Figure 32. Europe Paediatric Influenza Prevention Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Paediatric Influenza Prevention Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Paediatric Influenza Prevention Sales Market Share in Value by Application in 2025 Figure 35. Latin America Paediatric Influenza Prevention Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Paediatric Influenza Prevention Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Paediatric Influenza Prevention Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Paediatric Influenza Prevention Sales Market Share in Value by Application in 2025 Figure 39. North America Paediatric Influenza Prevention Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Paediatric Influenza Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Paediatric Influenza Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Paediatric Influenza Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Paediatric Influenza Prevention Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Paediatric Influenza Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Paediatric Influenza Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Paediatric Influenza Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Paediatric Influenza Prevention Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Paediatric Influenza Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Paediatric Influenza Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Paediatric Influenza Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Paediatric Influenza Prevention Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Paediatric Influenza Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Paediatric Influenza Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Paediatric Influenza Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Paediatric Influenza Prevention Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Paediatric Influenza Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Paediatric Influenza Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Paediatric Influenza Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Paediatric Influenza Prevention Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Paediatric Influenza Prevention Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Injection
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • Jiangsu GDK
  • GSK
  • Viatris
  • Sinovac
  • KM Biologics
  • Hulan Bio
  • CSL
  • CCBIO
  • BCHT
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paediatric Influenza Prevention Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paediatric Influenza Prevention Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paediatric Influenza Prevention Market by Type
  6. 1.3.1 Nasal Spray
  7. 1.3.2 Injection
  8. 1.4 Global Paediatric Influenza Prevention Market Size by Type
  9. 1.4.1 Global Paediatric Influenza Prevention Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Paediatric Influenza Prevention Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Paediatric Influenza Prevention Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Paediatric Influenza Prevention Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Paediatric Influenza Prevention Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Paediatric Influenza Prevention Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Paediatric Influenza Prevention Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Paediatric Influenza Prevention Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paediatric Influenza Prevention Industry Trends
  2. 2.2 Paediatric Influenza Prevention Industry Drivers
  3. 2.3 Paediatric Influenza Prevention Industry Opportunities and Challenges
  4. 2.4 Paediatric Influenza Prevention Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paediatric Influenza Prevention Revenue (2021-2026)
  2. 3.2 Global Top Players by Paediatric Influenza Prevention Sales (2021-2026)
  3. 3.3 Global Top Players by Paediatric Influenza Prevention Price (2021-2026)
  4. 3.4 Global Paediatric Influenza Prevention Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paediatric Influenza Prevention Major Company Production Sites & Headquarters
  6. 3.6 Global Paediatric Influenza Prevention Company, Product Type & Application
  7. 3.7 Global Paediatric Influenza Prevention Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paediatric Influenza Prevention Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paediatric Influenza Prevention Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paediatric Influenza Prevention Tier 1, Tier 2, and Tier 3
4 Paediatric Influenza Prevention Regional Status and Outlook
  1. 4.1 Global Paediatric Influenza Prevention Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paediatric Influenza Prevention Historic Market Size by Region
  3. 4.2.1 Global Paediatric Influenza Prevention Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paediatric Influenza Prevention Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paediatric Influenza Prevention Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paediatric Influenza Prevention Forecasted Market Size by Region
  7. 4.3.1 Global Paediatric Influenza Prevention Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paediatric Influenza Prevention Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paediatric Influenza Prevention Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paediatric Influenza Prevention by Application
  1. 5.1 Paediatric Influenza Prevention Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Paediatric Influenza Prevention Market Size by Application
  5. 5.2.1 Global Paediatric Influenza Prevention Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Paediatric Influenza Prevention Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Paediatric Influenza Prevention Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Paediatric Influenza Prevention Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Paediatric Influenza Prevention Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Paediatric Influenza Prevention Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Paediatric Influenza Prevention Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Paediatric Influenza Prevention Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Paediatric Influenza Prevention Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Jiangsu GDK
  8. 6.2.1 Jiangsu GDK Company Information
  9. 6.2.2 Jiangsu GDK Business Overview
  10. 6.2.3 Jiangsu GDK Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu GDK Paediatric Influenza Prevention Product Portfolio
  12. 6.2.5 Jiangsu GDK Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Paediatric Influenza Prevention Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Viatris
  20. 6.4.1 Viatris Company Information
  21. 6.4.2 Viatris Business Overview
  22. 6.4.3 Viatris Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Viatris Paediatric Influenza Prevention Product Portfolio
  24. 6.4.5 Viatris Recent Developments
  25. 6.5 Sinovac
  26. 6.5.1 Sinovac Company Information
  27. 6.5.2 Sinovac Business Overview
  28. 6.5.3 Sinovac Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Paediatric Influenza Prevention Product Portfolio
  30. 6.5.5 Sinovac Recent Developments
  31. 6.6 KM Biologics
  32. 6.6.1 KM Biologics Company Information
  33. 6.6.2 KM Biologics Business Overview
  34. 6.6.3 KM Biologics Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 KM Biologics Paediatric Influenza Prevention Product Portfolio
  36. 6.6.5 KM Biologics Recent Developments
  37. 6.7 Hulan Bio
  38. 6.7.1 Hulan Bio Company Information
  39. 6.7.2 Hulan Bio Business Overview
  40. 6.7.3 Hulan Bio Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hulan Bio Paediatric Influenza Prevention Product Portfolio
  42. 6.7.5 Hulan Bio Recent Developments
  43. 6.8 CSL
  44. 6.8.1 CSL Company Information
  45. 6.8.2 CSL Business Overview
  46. 6.8.3 CSL Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSL Paediatric Influenza Prevention Product Portfolio
  48. 6.8.5 CSL Recent Developments
  49. 6.9 CCBIO
  50. 6.9.1 CCBIO Company Information
  51. 6.9.2 CCBIO Business Overview
  52. 6.9.3 CCBIO Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CCBIO Paediatric Influenza Prevention Product Portfolio
  54. 6.9.5 CCBIO Recent Developments
  55. 6.10 BCHT
  56. 6.10.1 BCHT Company Information
  57. 6.10.2 BCHT Business Overview
  58. 6.10.3 BCHT Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BCHT Paediatric Influenza Prevention Product Portfolio
  60. 6.10.5 BCHT Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Paediatric Influenza Prevention Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Paediatric Influenza Prevention Sales by Country
  2. 7.1.1 North America Paediatric Influenza Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paediatric Influenza Prevention Sales by Country (2021-2026)
  4. 7.1.3 North America Paediatric Influenza Prevention Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paediatric Influenza Prevention Market Size by Country
  6. 7.2.1 North America Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paediatric Influenza Prevention Market Size by Country (2021-2026)
  8. 7.2.3 North America Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paediatric Influenza Prevention Sales by Country
  2. 8.1.1 Europe Paediatric Influenza Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paediatric Influenza Prevention Sales by Country (2021-2026)
  4. 8.1.3 Europe Paediatric Influenza Prevention Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paediatric Influenza Prevention Market Size by Country
  6. 8.2.1 Europe Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paediatric Influenza Prevention Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paediatric Influenza Prevention Sales by Country
  2. 9.1.1 Asia-Pacific Paediatric Influenza Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paediatric Influenza Prevention Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paediatric Influenza Prevention Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paediatric Influenza Prevention Market Size by Country
  6. 9.2.1 Asia-Pacific Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paediatric Influenza Prevention Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paediatric Influenza Prevention Sales by Country
  2. 10.1.1 South America Paediatric Influenza Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paediatric Influenza Prevention Sales by Country (2021-2026)
  4. 10.1.3 South America Paediatric Influenza Prevention Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paediatric Influenza Prevention Market Size by Country
  6. 10.2.1 South America Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paediatric Influenza Prevention Market Size by Country (2021-2026)
  8. 10.2.3 South America Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paediatric Influenza Prevention Sales by Country
  2. 11.1.1 Middle East and Africa Paediatric Influenza Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paediatric Influenza Prevention Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paediatric Influenza Prevention Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paediatric Influenza Prevention Market Size by Country
  6. 11.2.1 Middle East and Africa Paediatric Influenza Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paediatric Influenza Prevention Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paediatric Influenza Prevention Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paediatric Influenza Prevention Value Chain Analysis
  2. 12.1.1 Paediatric Influenza Prevention Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paediatric Influenza Prevention Production Mode & Process
  7. 12.2 Paediatric Influenza Prevention Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paediatric Influenza Prevention Distributors
  10. 12.2.3 Paediatric Influenza Prevention Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst